Vantage Consulting Group’s Exelixis EXEL Stock Holding History

Vantage Consulting Group’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-930	Closed	-$19K	–	577
2020 Q4	$19K	Buy	+930	New	+$19.5K	﹤0.01%	892

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Vantage Consulting Group's EXEL Position: Q1 2021 in Review

Vantage Consulting Group sold out of Exelixis (EXEL) in Q1 2021, closing a stake of 930 shares — an estimated $19K sold.

Vantage Consulting Group first reported a position in EXEL in Q4 2020 and held it in 1 quarter. The position peaked at $19K in Q4 2020. 347 funds tracked by Wall St. Rank hold EXEL as of Q1 2021.

Vantage Consulting Group reported no remaining Exelixis position as of Q1 2021 after selling out during the quarter.
Vantage Consulting Group sold 930 Exelixis shares in Q1 2021, an estimated $19K.
Vantage Consulting Group first reported a position in Exelixis in Q4 2020 and held it in 1 quarter.
Vantage Consulting Group's Exelixis position peaked at $19K in Q4 2020.
347 funds tracked by Wall St. Rank held Exelixis as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.